Podcast appearances and mentions of Erik Davis

Recently on Relentless Health Value, we've been tinkering around with a few recurring themes—recurring through lines—that are just true about American healthcare these days. In this episode of Relentless Health Value, host Stacey Richter speaks with Dr. Christine Hale about high cost claimants and the implications for healthcare plans in 2025 and beyond. They discuss the importance of trust in patient care, the financial incentives behind patient steering, and the critical role of timely and comprehensive data analysis. Dr. Hale emphasizes the need for an integrated approach to medical and pharmacy claims data to avoid expensive consequences and improve patient outcomes. She also shares strategies for plan sponsors to effectively manage high cost claimants through evidence-based care, appropriate treatment settings, and creative problem-solving, while underlining the importance of patient engagement and satisfaction. Don't miss next week's episode with Dr. Eric Bricker for a deeper dive into these topics. === LINKS ===

April 4th - Stewart Dobson, Erik Davis, Brian Mulvey, Jessica Radloff

Fandango Managing Editor, Erik Davis, joins us once again on Pop Culture Weekly to discuss the results of Fandango's 2025 Moviegoing Trends and Insights Study, including the Most Anticipated Movies of Summer 2025 as voted by YOU! Kyle McMahon and Erik explore everything from the thrilling action sequences of "Mission Impossible: Final Recokining" to James Gunn's fresh take on Superman, featuring the charming Krypto the Superdog. Erik brings us the latest insights from Fandango's study on movie-going trends, where concessions remain king and premium formats like IMAX and Dolby are drawing audiences back to the theaters. The conversation takes a deeper dive into the evolution of the movie theater experience, spotlighting exciting developments like themed experiences and the growing popularity of theaters such as Alamo Drafthouse. We also tackle the great debate over cell phone use during films, as some theaters experiment with screenings tailored to all preferences. As we preview the summer movie lineup, our excitement is palpable for the debut of Marvel's "Fantastic Four: First Steps," hailed for its 60s retro-futuristic flair, and the high anticipation for "Jurassic World Rebirth." With Erik's expert insights and our shared passion for cinema, this episode promises to be a cinematic feast for movie lovers everywhere.Kyle McMahon's Death, Grief & Other Sh*t We Don't Discuss is now streaming: https://www.deathandgrief.show/Chapter-One-The-Diagnosis-AKA-WTF/---------------Get all the Pop Culture Weekly podcast info you could want including extra content, uncut interviews, photos, videos & transcripts at: https://podcast.popcultureweekly.comWatch celebrity interviews at: https://www.facebook.com/realkylemcmahon/videosor Pop Culture Weekly YouTube at: https://www.youtube.com/@popcultureweeklyRead the latest at http://www.PopCultureWeekly.comFollow Kyle on:Facebook: http://www.facebook.com/realkylemcmahonInstagram: http://www.instagram.com/kmacmusicTikTok: http://www.tiktok.com/@kyle2uYouTube: https://www.youtube.com/@popcultureweeklyWebsite: http://www.kylemcmahon.me

March 28th - Erik Davis, John Lee Bishop

In part 2 of episode 469, host Stacey Richter discusses the implications of Medicare site neutral payments and Health Savings Account (HSA) reforms with James Gelfand, president and CEO of the ERISA Industry Committee (ERIC).  The episode details how plan sponsors should adapt to Medicare's site neutral payment policies aimed at curbing hospital consolidation and inflated prices through facility fees and markups. Gelfand provides insights into how HSA reforms currently in Congress could expand the scope of preventive care covered before deductibles are met, benefitting both employers and employees.  The conversation also touches on the challenges high deductible health plans pose and the potential benefits of codifying recent IRS guidance to allow greater flexibility in pre-deductible coverage. The discussion underscores the importance of plan sponsors staying ahead of Medicare policies to avoid higher costs. === LINKS ===

John Crowley's Little, Big is, at once, a family saga, a fairy tale, an occult thriller, an idyll, a dystopia, as well as a meditation on myth and history, the real and the fantasy, memory and imagination. Little, Big is also a book that JF and Phil have been planning to discuss for as long as Weird Studies has existed. In this episode, they are joined by writer and scholar Erik Davis to explore the enduring charms and mysteries of one of the greatest—and most underrated—American novels of the late twentieth century. Order Christian Bunyan's Weird Studies poster here (https://www.christianbunyan.com/Weird-Studies). Visit Weirdosphere (http://www.weirdosphere.org) for more details on Erik Davis's ongoing course, The Three Stigmata of Philip K. Dick. Support us on Patreon (https://www.patreon.com/weirdstudies). Buy the Weird Studies soundtrack, volumes 1 (https://pierre-yvesmartel.bandcamp.com/album/weird-studies-music-from-the-podcast-vol-1) and 2 (https://pierre-yvesmartel.bandcamp.com/album/weird-studies-music-from-the-podcast-vol-2), on Pierre-Yves Martel's Bandcamp (https://pierre-yvesmartel.bandcamp.com) page. Listen to Meredith Michael and Gabriel Lubell's podcast, Cosmophonia (https://cosmophonia.podbean.com/). Visit the Weird Studies Bookshop (https://bookshop.org/shop/weirdstudies) Find us on Discord (https://discord.com/invite/Jw22CHfGwp) Get the T-shirt design from Cotton Bureau (https://cottonbureau.com/products/can-o-content#/13435958/tee-men-standard-tee-vintage-black-tri-blend-s)! REFERENCES John Crowley, Little, Big (https://bookshop.org/a/18799/9780061120053) Roald Dahl, Charlie and the Chocolate Factory (https://bookshop.org/a/18799/9780142410318) Thomas Mann, The Magic Mountain (https://bookshop.org/a/18799/9781774640449) Eric Davis, interview with Neil Gaiman and Rachel Pollack (https://techgnosis.com/the-gods-of-the-funny-books/) David Lynch (dir.), Lost Highway (https://www.imdb.com/title/tt0116922/) America, “The Last Unicorn” (https://www.youtube.com/watch?v=51Ez6ZVz68c&ab_channel=America-Topic) John Cooper Powys, [A Glastonbury Romance](https://www.goodreads.com/book/show/959613.AGlastonburyRomance) J. R. R. Tolkein, The Lord of the Rings (https://bookshop.org/a/18799/9780547951942) Patrick Harpur, Daimonic Reality (https://bookshop.org/a/18799/9780937663615) Lord Dunsany, (https://en.wikipedia.org/wiki/Lord_Dunsany) Irish novelist Special Guest: Erik Davis.

Where do we need boundaries, and where do we need flows? And how can we ensure that we can redistribute them according to the changing needs of any given moment? These are the kinds of questions I would ask if I were trying to meta-solve a meta-crisis, and this is why I'm glad to share this conversation with you. Today's guest Aishwarya Khanduja, is a fellow living inquiry, an incandescent interrobang just like myself, the founder of The Analogue Group.Announcements: * We will book club Federico Campagna's Prophetic Culture: Recreation for Adolescents on April 26th, along with pre-game discussion in the Future Fossils Discord Server's members-only channels. This book is a masterpiece of thinking otherwise and just what we need to attend to as transition from one mode of worlding to another…I can't wait to talk about it with you and hear everyone's reflections! * I am finally publishing “The Big Machine”, my anthem for the Screen Age, and will drop my new single and music video on April 1st, so dive into the show notes and pre-save it on Spotify, follow my YouTube channel for notifications when the song goes live, and prime yourself by meditating on the question:“How long can you go without looking at your phone?”Subscribe, Rate, & Comment on YouTube • Apple Podcasts • SpotifyIf you like this show, dig into the archives and consider making tax-deductible donations at every.org/humansontheloop. (You'll get all the same perks as Substack patrons.)Project LinksRead the project pitch & planning docDig into the full episode and essay archivesJoin the open online commons for Wisdom x Technology on DiscordThe Future Fossils Discord Server is where we'll do the book club discussions.Contact me about partnerships, consulting, your life, or other mysteries!ReadsHarnessing the power of our subconscious mindShaping the future with fictional storiesSocratic SalonsAirpods are ruining the worldA case for strategic ignorance by designTranscendence: An Emergent Career LifeHow to know what to doTasty Morsels from Groovy HubsThe Pathless Path by Paul MillerdScatter, Adapt, and Remember by Annalee Newitz Quarterlife by Satya Doyle ByockArtificial You by Susan SchneiderThe_Human_Roots_of_Artificial_Intelligence_A_Commentary_on_Susan_Schneider's_Artificial_You by Inês HipólitoOther MentionsStephanie LeppAri KushnirSøren KierkegaardPeter Sheridan DoddsPriya Rose of Fractal UniversityNadia AsparouhovaMark Pesce on Erik Davis' Expanding MindKatalin KarikóJim O'ShaughnessyEvan MiyazonoK. Allado McDowellAmber Case & Michael ZarghamPaul GrahamKurt VonnegutSrinivasa RamanujanCharles DarwinAlbert EinsteinWinston ChurchillDaniel KahnemannAlbert ClaudeAlfred AdlerGregor MendelAflred Russel Wallace This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit michaelgarfield.substack.com/subscribe

March 21st - Stewart Dobson, Erik Davis, Eric Aronson, Edwin McCain

In this episode, JF and Phil continue their conversation on the wedge, their figure for the epistemological divide between approaching reality from the heart and exploring it with the mind. As the discussion unfolds, the wedge begins to reveal itself not as a rigid binary but as a spectrum—one that stretches from ultimate thickness to ultimate thinness. Could thinking, then, may be the art of navigating this epistemic gradient, seeking the sweet spot where the self meets the world, each on the other's terms? Visit Weirdosphere (http://www.weirdosphere.org) for more details on Erik Davis's upcoming course, The Three Stigmata of Philip K. Dick. Support us on Patreon (https://www.patreon.com/weirdstudies). Buy the Weird Studies soundtrack, volumes 1 (https://pierre-yvesmartel.bandcamp.com/album/weird-studies-music-from-the-podcast-vol-1) and 2 (https://pierre-yvesmartel.bandcamp.com/album/weird-studies-music-from-the-podcast-vol-2), on Pierre-Yves Martel's Bandcamp (https://pierre-yvesmartel.bandcamp.com) page. Listen to Meredith Michael and Gabriel Lubell's podcast, Cosmophonia (https://cosmophonia.podbean.com/). Visit the Weird Studies Bookshop (https://bookshop.org/shop/weirdstudies) Find us on Discord (https://discord.com/invite/Jw22CHfGwp) Get the T-shirt design from Cotton Bureau (https://cottonbureau.com/products/can-o-content#/13435958/tee-men-standard-tee-vintage-black-tri-blend-s)! REFERENCES Weird Studies, Episode 155 on ‘The Unbinding' (https://www.weirdstudies.com/155) Alan Chapman, Advanced Magick for Beginners (https://bookshop.org/a/18799/9781904658412) Quentin Meillassoux, After Finitude (https://bookshop.org/a/18799/9780826496744) The Principle of Sufficient Reason (https://en.wikipedia.org/wiki/Principle_of_sufficient_reason) Baruch Spinoza, Ethics (https://bookshop.org/a/18799/9780140435719) Weird Studies, Episode 139 on the power of art (https://www.weirdstudies.com/139) Phil Ford, “The View from the Cheap Seats” Arnold Schoenberg, (https://en.wikipedia.org/wiki/Arnold_Schoenberg) Austrian composer Jaques Vallee, Passport to Magonia (https://bookshop.org/a/18799/9780987422484)

March 7th - Stewart Dobson, Erik Davis, Alfonso Rebeiro, Bill Guttentag

This episode has three chapters. Each one answers a key question, and, bottom line, it all adds up to action steps directly and indirectly for many, including plan sponsors probably, community leaders, and also hospital boards of directors. Here's the three chapters in sum. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Chapter 1: Are commercial insurance premiums rising faster than the inflation rate? And if so, is the employee portion of those premiums also rising, meaning a double whammy for employees' paychecks (ie, premium costs are getting bigger and bigger in an absolute sense, and also employees' relative share of those bigger costs is also bigger)? Spoiler alert: yes and yes. Chapter 2: What is the biggest reason for these premium increases? Like, if you look at the drivers of cost that underpin those rising premiums, what costs a lot that is making these premiums cost a lot? Spoiler alert: It's hospitals and the price increases at hospitals. And just in case anyone is wondering, this isn't, “Oh, chargemasters went up” or some kind of other tangential factor. We're talking about the revenue that hospitals are taking on services delivered has gone up and gone up way higher than the inflation rate. In fact, hospital costs have gone up over double the amount that premiums have gone up. Wait, what? That's a fact that Dr. Vivian Ho said today that threw my brain for a loop: Hospital costs have gone up over double the amount that premiums have gone up. Chapter 3: Is the reason that hospital prices have rocketed up as they have because the underlying costs these hospitals face are also going up way higher than the inflation rate? Like, for example, are nurses' salaries skyrocketing and doctors are getting paid a lot more than the inflation rate? Stuff like this. Too many eggs in the cafeteria. Way more charity care. Bottom line, is an increase in underlying costs the reason for rising hospital prices? Spoiler alert: no. No to all of the above. And I get into this deeply with Dr. Vivian Ho today. But before I do, I do just want to state with three underlines not all hospitals are the same. But yeah, you have many major consolidated hospitals crying about their, you know, “razor-thin margins” who are, it turns out, incentivizing their C-suites to do things that ultimately wind up raising prices. I saw a PowerPoint flying around—you may have seen it, too—that was apparently presented by a nonprofit hospital at JP Morgan, and it showed this nonprofit hospital with a 15.1% EBITDA (earnings before interest, taxes, depreciation, and amortization) in 2024. Not razor thin in my book. It's a, the boards of directors are structuring C-suite incentives in ways that ultimately will raise prices. If you want to dig in a little deeper on hospital boards and what they may be up to, listen to the show with Suhas Gondi, MD, MBA (EP404). Vivian Ho, PhD, my guest today, is a professor and faculty member at Rice University and Baylor College of Medicine. Her most major role these days is working on health policy at Baker Institute at Rice University. Her work there is at the national, state, and local levels conducting objective research that informs policymakers on how to improve healthcare. Today on the show, Professor Vivian Ho mentions research with Salpy Kanimian and Derek Jenkins, PhD. Alright, so just one quick sidebar before we get into the show. There is a lot going on with hospitals right now. So, before we kick in, let me just make one really important point. A hospital's contribution to medical research, like doing cancer clinical trials, is not the same as how a hospital serves or overcharges their community or makes decisions that increase or reduce their ability to improve the health and well-being of patients and members who wind up in or about the hospital. Huge, consolidated hospital networks can be doing great things that have great value and also, at the exact same time, kind of harmful things clinically and financially that negatively impact lots of Americans and doing all of that simultaneously. This is inarguable. Also mentioned in this episode are Rice University's Baker Institute for Public Policy; Baker Institute Center for Health Policy; Suhas Gondi, MD, MBA; Salpy Kanimian; Derek Jenkins, PhD; Byron Hugley; Michael Strain; Dave Chase; Zack Cooper, PhD; Houston Business Coalition on Health (HBCH); Marilyn Bartlett, CPA, CGMA, CMA, CFM; Cora Opsahl; Claire Brockbank; Shawn Gremminger; Autumn Yongchu; Erik Davis; Ge Bai, PhD, CPA; Community Health Choice; Mark Cuban; and Ferrin Williams, PharmD, MBA. For further reading, check out this LinkedIn post.   You can learn more at Rice University's Center for Health Policy (LinkedIn) and Department of Economics and by following Vivian on LinkedIn.   Vivian Ho, PhD, is the James A. Baker III Institute Chair in Health Economics, a professor in the Department of Economics at Rice University, a professor in the Department of Medicine at Baylor College of Medicine, and a nonresident senior scholar in the USC Schaeffer Center for Health Policy and Economics. Ho's research examines the effects of economic incentives and regulations on the quality and costs of health care. Her research is widely published in economics, medical, and health services research journals. Ho's research has been funded by the National Institutes of Health (NIH), the Agency for Healthcare Research and Quality, the American Cancer Society, and Arnold Ventures. Ho has served on the Board of Scientific Counselors for the National Center for Health Statistics, as well as on the NIH Health Services, Outcomes, and Delivery study section. She was elected as a member of the National Academy of Medicine in 2020. Ho is also a founding board member of the American Society for Health Economists and a member of the Community Advisory Board at Blue Cross Blue Shield of Texas. Ho received her AB in economics from Harvard University, a graduate diploma in economics from The Australian National University, and a PhD in economics from Stanford University.   05:12 Are insurance premiums going up? 05:59 What is the disparity between cost of insurance and wage increases? 06:21 LinkedIn post by Byron Hugley. 06:25 Article by Michael Strain. 06:46 How much have insurance premiums gone up for employers versus employees? 09:06 Chart showing the cost to insure populations of employees and families. 10:17 What is causing hospital prices and insurance premiums to go up so exponentially? 12:53 Article by (and tribute to) Uwe Reinhardt. 13:49 EP450 with Marilyn Bartlett, CPA, CGMA, CMA, CFM. 14:01 EP452 with Cora Opsahl. 14:03 EP453 with Claire Brockbank. 14:37 EP371 with Erik Davis and Autumn Yongchu. 15:28 Are razor-thin operating margins for hospitals causing these rising hospital prices? 16:56 Collaboration with Marilyn Bartlett and the NASHP Hospital Cost Tool. 19:47 What is the explanation that hospitals give for justifying these profits? 23:16 How do these hospital cost increases actually happen? 27:06 Study by Zack Cooper, PhD. 27:35 EP404 with Suhas Gondi, MD, MBA. 27:50 Who typically makes up a hospital board, and why do these motivations incentivize hospital price increases? 30:12 EP418 with Mark Cuban and Ferrin Williams, PharmD, MBA. 33:17 Why is it vital that change start at the board level?   You can learn more at Rice University's Center for Health Policy (LinkedIn) and Department of Economics and by following Vivian on LinkedIn.   Vivian Ho discusses #healthinsurance #premiums and #hospitalpricing on our #healthcarepodcast. #healthcare #podcast #changemanagement #healthcareleadership #healthcaretransformation #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Chris Crawford (EP465), Al Lewis, Betsy Seals, Wendell Potter (Encore! EP384), Dr Scott Conard, Stacey Richter (INBW42), Chris Crawford (EP461), Dr Rushika Fernandopulle, Bill Sarraille, Stacey Richter (INBW41)  

February 14th - Stewart Dobson, Erik Davis, Kelsey Cook

February 7th - Stewart Dobson, Steve Green, Erik Davis, Tom Satterly

January 31st - Stewart Dobson, Erik Davis, Mara Campo and Yoruba Richen

Subscribe, Rate, & Review on YouTube • Spotify • Apple PodcastsThis week we speak with K Allado-McDowell, artist, musician, and co-founder of the Artists & Machine Intelligence program at Google. K pioneered human-computer co-authorship with the book Pharmako-AI, as well as Air Age Blueprint, Amor Cringe, and the graphic novel Outside, plus works in opera and ritual. Their work reveals the human as inherently relational and ecological, technology as something nature's doing, and the new vistas made legible by technology as a fertile zone within which we can redefine identity and story from a radically transformed awareness. Pharmako-AI, the first book to be co-written with GPT-3 in 2020, sets the tone: mutually interdependent co-arising of selfhood through linguistic interactions between animal, vegetable, and mineral intelligences, AI as an adjunct to our awakening sense of co-imbrication in and as a plural and evolving world.Project LinksPlans, invited thinkers, and needsHire me for consulting or advisory workMake tax-deductible donations to Humans On The LoopBrowse the HOTL reading list and support local booksellersTend a community knowledge garden in the Wisdom x Technology Discord serverMeet delightful fellow weirdos in the private Future Fossils Facebook groupChapters0:00:00 – Teaser0:01:34 – Intro0:06:54 – Who is Kenric Allado-McDowell?0:13:12 – Entering Linguistic Hyperspace0:31:36 – Neural, Network, Immersive, Broadcast Media0:48:10 – The Poison Path of Machine Intelligence1:05:10 – Post-Cyperpunk Love & Nonduality1:17:55 – Recommendations1:21:02 – OutroMentionsK's “Neural Interpellation”K's “Designing Neural Media”Dale Pendell's Pharmako/Gnosis: Plant Teachers and The Poison PathPharmako-AIK in conversation with Erik Davis at The AlembicJacques Vallee's The Invisible CollegeJohn KeatsRichard DoyleEduardo KohnSETIDavid Abrams' The Spell of The SensuousRobert RauschenbergJohn CageBell LabsFred Turner's The Democratic SurroundStanford UniversityThe Committee for National MoraleMargaret MeadGregory BatesonCharles & Ray EamesEdward SteichenStan VanDerBeekTerence McKennaReplika AIRay KurzweilMidjourneyJoseph SchumpeterJakob Johann von UexküllJean BaudrillardMiike SnowJohn DanaherSpikeRudolf SteinerTimothy MortonKrishnamurtiAlexander Von HumboldtAndrea WulfNick LandNora Khan Paul Preciado This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit michaelgarfield.substack.com/subscribe

January 24th - Erik Davis, Bruce Laird, Luciane Buchanan

January 17th - Erik Davis, Arielle Kebbel, Matt Kester, Bill Pentland

January 9th - Erik Davis, Elijah Wald

December 20th - Erik Davis, Pam Houck, Rick Vach

Subscribe, Rate, & Review on YouTube • Spotify • Apple PodcastsThis Week's GuestWhen, suddenly, the barrier between “imagination” and “reality” evaporates as our familiar notions of here/there, now/then, in/out, and other/self twist up into a ball of non-Euclidean spaghetti, whom better to help steer the course through these “turbulent philosophical waters” than Richard Doyle, aka “M0b1ius”, Edwin Erle Sparks Professor at Penn State Center for Humanities and Information in the College of Liberal Arts? After his postdoctoral research at MIT in History and Philosophy of the Life Sciences, Doyle wrote The Wetwares Trilogy, a sequence of books on the history of information biology that reached its climax with one of my favorite reads of all time, Darwin's Pharmacy: Sex, Plants, and The Evolution of the Noosphere. He is also the author of The Genesis of Now: Self Experiments with the Bible & the End of Religion and Into The Stillness: Dialogues on Awakening Beyond Thought (with Gary Weber), and has taught courses on “aliens, Philip K. Dick, nanotechnology, rebellion itself, ecstasy, Sanskrit rhetorical traditions, Burroughs, basic argumentation, The Non Dual Bible, and everything in between.” I discovered Doyle through his appearances on my first favorite podcast, Erik Davis' Expanding Mind, and in the thirteen years since he has shown up for me time and time again as mentor, friend, and inspiration. And since this project is, ostensibly, a way of training my own language model to reflect the wisdom of my friends and colleagues, I can think of no one else I'd rather prime the batch. It is my great privilege and honor to be able to have him as the first guest in this series, as a way of of helping set the tone for everything that is to come…LinksRichard Doyle's faculty web page and publicationsLearn more about this project and read the essays so far (1, 2, 3, 4).Make tax-deductible donations to Humans On The LoopBrowse my reading list and support local booksellersJoin the Holistic Technology & Wise Innovation Discord serverJoin the private Future Fossils Facebook groupHire me for consulting or advisory workChapters0:00:00 – Teaser0:03:36 – Episode Intro0:12:44 – Introducing Richard Doyle0:29:33 – The Ego as Inflammation0:33:58 – Practicing Care in The Planet-Wide Makerspace0:48:30 – Digital Connection vs. Embodied Connection0:55:46 – Psychedelics as Training Wheels for Transhumanism1:02:43 – “Storytelling” Isn't A Professional Service (??)1:05:25 – Techniques for Reclaiming Attention & Finding Peace1:15:22 – Meditation as “The Halting Problem”1:17:30 – Beyond The Limits of Science1:22:17 – AI-Enabled Extraction vs. AI-Enabled Abundance1:38:40 – Closing RemarksReflectionsMuch of tech ethics discourse concerns itself with whether humans are “in the loop” or “out of the loop” — whether people get to call the shots. But there is always more than one loop. Most of the things our fleshy bodies do are local decisions made before we ever become conscious of them, if we ever do…and yet evolution clearly found some value in reflection, self-awareness, reflex inhibition, and the will that quiets maladaptive impulse. Widening our frame to see the way that humans are always-already intertwingled with our ecosystems, we can see ourselves as made of interference patterns between nested feedback loops — as focal points of conscious agency dependent on and acting in a massive, endlessly surprising web of automatic processes. For as long as we've been people we have never really “called the shots” but rather cultivated our response-ability within a cosmos made of entities whose otherness and mystery remained persistently opaque…and ritualized ways to live amidst this mystery in full recognition of the unity from which we cannot isolate ourselves.And this is only one of indefinitely many valid ways to understand the human. Like the telescope and microscope before them, language models reveal fresh perspectives on familiar landscapes. We do not need to leave our solar system to find “strange new worlds” awaiting us in places as familiar as our own minds and bodies. While most of the conversation lately seems to be about the power these new maps confer and whether it can be distributed more evenly, AI provides a new set of affordances for mystics for the transformation of our consciousness that can dissolve our wicked problems in a higher logical order. “What can I do?” becomes “Who am I?” and yields endlessly evolving and kaleidoscopic answers that provoke ongoing inquiry. To see the ways in which we are, as individuals, not just “connected” but precipitate as aggregates, in fields of constellated data, prompts a figure-ground reversal in which selves no longer hold their primacy as ground truth of our being, but show up last as we make inferences and draw stories from unbroken and inseparable experience.Something fundamental changes when we shift to seeing “human” and “non-human” as two stable patterns of recursive self-perception emerging from a single fabric of unfolding possibility: we find the opportunity to question what we're trying to achieve, to notice the ungrounded and conditional reality of narrative, to operate on our own “source code” and adjust our goals accordingly.If we can find the curiosity to ask ourselves if our fears and inadequacies really help us live the lives we want, we can follow it upstream to where each moment offers fresh, distinctive landscapes in which to explore and play and learn. In doing so, we rediscover vast and potent creativity. Instead of asking whether we can do more, we can ask “What do we want to do, and why is that desire substantiated?”This kind of meaning-making isn't just a luxury but an essential aspect of all efforts to survive and to succeed. The best way to get unstuck is to orient ourselves and take a different tack. We all know something isn't working. It's time to ask if, maybe, this is due to “user error” and the answer doesn't lie in new technologies, but in the simplest and most ancient truths available. We cannot control the world because we are the world — and, this entails a sense of radical responsibility to play our way into more well-adapted stories, models of the world we hold with humor and humility as they carve channels in the space of shared attention that coordinate us into futures good and true and beautiful.In other words, the magical technologies inspiring so much religious fear and fervor are both Towers of Babel and fingers pointing to the Moon. They are weird, unprecedented, and sublime — and they are business as usual on Planet Earth, where we have always come awake in medias res amidst unfathomable changes and unknowable intelligence. Recognizing this, we gain access to deep continuity and the place from which we can, at last, engage the question of “What Now?” with discipline and limber rigor suitable to the profound complexity we face.Digital technologies are psychedelic. We've been on a bad trip. It's time for us wiggle out, dream better, and allow a more capacious, plural, and harmonious humanity to take the oars together in whatever novel wonders may arise — to neither “give way to astonishment” nor let our fears steer us into the rocks. Humans On The Loop is an investigation of how awesome it could be, right now, to fully give in to the paradox, and notice how its knots untie in hyperspace, and revisit all our looming crises with more presence, grace, and understanding — and more lucid (dare I say, productive?) questions.One of those questions is how to apply the lessons of the living generations of psychonauts and psychedelic therapists to the vertiginous information and attention vortices in which we now found ourselves swirling. Maps of the World Wide Web look very much like brain scans of the amped-up functional connectivity between ordinarily inhibited brain regions in a psilocybin tripper. When the walls come down — when every node has edges with each other node, and average path length drops to one — how do we prioritize? What paths do we decide to cut through the emergent “intertwingularity”? Which apparitions do we honor, and which do we ignore? (And how?) Some familiar tropes that we might use to guide us: “test your drugs”, “get grounded”, “set and setting”, “integration counseling”…MentionsGenerated by NotebookLM. Please let me know if you notice any errors or omissions!* Richard Doyle* Michael Garfield * Gary Weber* Shankara* Trey Conner* Nora Pandoro* Erik Davis* Joshua DiCaglio* John Perry Barlow* Naomi Most* Nate Hagens* Daniel Schmachtenberger* Tyson Yunkaporta* Martin Luther King Jr.* Mahatma Gandhi* John Von Neumann* Subhash Kak* Iain McGilchrist* Timothy Morton* Stuart Kauffman* Dean Radin* Brian Josephson* Monica Gagliano* Christoph Koch* Gregory Bateson* Elon Musk* Robert Rosen* H.P. Lovecraft* Philip K. Dick* Herbert Simon* Douglas Rushkoff* Sri Aurobindo This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit michaelgarfield.substack.com/subscribe

Syrian dictator Bashar al-Assad has fled to Moscow after rebels toppled his regime and took control of the Syrian government over the weekend. CBS News homeland security contributor Samantha Vinograd has a look at the situation.Ethan Clark, a 22-year-old self-taught forecaster, received one of North Carolina's highest civilian honors for his reporting during Hurricane Helene. CBS News contributor David Begnaud has the story.Morris Chestnut and Mindy Kaling announced the nominations for the 82nd annual Golden Globes Monday morning. Fandango managing director Erik Davis has a look at the nominees.Award-winning actor and comedian Billy Crystal's newest project is a psychological thriller on Apple TV+ called "Before." Crystal joined "CBS Mornings" to talk about producing and starring in the new series.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

November 26th - Drew Curtis, Erik Davis, David Frei, Tzi Ma

November 22nd - Stewart Dobson, Erik Davis, Clarke Peters, Josh Gates

November 15th - Erik Davis from Fandango, Tim O'Heir from Parks and Rec

November 8th - Erik Davis from Fandango.com

The Deadcast uncovers the long-lost tape of the Dead & San Francisco's Sufi Choir at Winterland in 1971, telling its untold story with composer Allaudin Mathieu, finding hidden connections to big band jazz, longform improv comedy, & spirituality, plus an appearance by Wavy Gravy.Guests: Allaudin Mathieu, Wavy Gravy, Michael Parrish, John “Tex” Coate, Erik Davis, Christopher CoffmanSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This show is going to be a little bit different because what we're going to do today is offer some advice to those who may work at a pharma company. But before we get into this advice portion of the discussion, let's start here. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. Probably we're gonna have people listening to this episode who maybe are not in our normal tribe of Relentless Health Value listeners. While there are, for sure, regular listeners who work at pharma companies, there might be some newbies on the scene here. And to you, I say welcome. I hope that you feel right at home here. You know what, though? Many of us, including myself often enough, are slightly uncomfortable. Because this is the place where we all kind of look at ourselves in the mirror. We all live in glass houses, after all—everyone in the healthcare industry. There's no devils and no angels here. And the trick is maximizing the good and minimizing the not so good so that we all wind up with the highest net positive possible for patients. So, around here, we do not shy away from saying what needs to be said so that we all can find a way forward to serve the patient. We cannot solve problems, after all, that we have not taken a cold, hard look at. Yeah. So, today I am speaking with Brian Reid. I have been very much looking forward to speaking with Brian Reid, who many may know from his really great newsletter and really insightful LinkedIn posts. Brian Reid's advice, which he delivers in the episode that follows in sum. Spoiler alert here, but I also will say that he is much more eloquent than me, and the nuances are a thing. So, please do listen to the whole show. But Brian's piece of advice number one for Pharma (and really any product or service frankly), but piece of advice number one is this: Get a really solid bead on what value means—not just to PBMs (pharmacy benefit managers) or contract pharmacies or wholesalers who are middlemen but to the ultimate purchasers, the ones whose wallets the money is actually coming out of to pay the bill. Meaning, plan sponsors, such as self-insured employers or unions, patients themselves or members, and taxpayers. Again, how does value accrue to the ultimate purchasers like plan sponsors, patients/members, or taxpayers? Everybody else in the drug supply chain, let's be clear, is in the middle pushing money around that came out of somebody else's wallet. These middlemen have their own interests that may, for sure, may or may not be aligned with the interests of the ultimate purchasers. Getting value realized by patients will depend on understanding what the value is to these ultimate purchasers and then not getting derailed by any middleman who may not be so aligned. As a sidebar on this number one piece of advice, the whole “what's your value” and influence coloring this value equation made by ultimate purchasers is the prevailing beliefs of these ultimate purchasers, relative to Pharma, how they perceive the pharma industry. Whether it's earned or not—and this is not what we're gonna discuss today—but earned or not, Pharma does not have a great reputation with these folks right now. And this matters. Brian has a lot to say on this topic, which is fascinating. So, you should listen. Number two piece of advice that Brian Reid delivers in the podcast that follows that we talk about: Consider inching into the fray around benefit design. Rightfully so, there's always a lot of talk about patient affordability at pharma companies; but if I was gonna point to one thing that impacts affordability more than anything else, it'd be benefit design. There's only a small, underfunded cadre right now of folks out there (Mark Cuban aside, actually); but there's only a really small number of folks who never have any money who are really helping plan sponsors understand the impact on patients of some of the choices that they are making. I mean, personally, I could think of 10 things to do right off the top of my head that could help plan sponsors not get inadvertently screwed in this realm alone, just thinking they're saving money when, in reality, they are harming patients and not saving money. There's probably a lot of opportunities to communicate these kinds of things that are really win-win collaborations. Number three piece of advice that we talk about in the conversation that follows with Brian Reid: Keep an eye on hospital consolidation and vertical integration in the payer space. Consolidation raises prices and impedes patient affordability. This is as per study after study after study. Consolidation raises prices and sometimes considerably. Here's a part B to this third piece of advice about consolidation. There's sometimes wild swings in prices at different large, consolidated health systems in the exact same geography. Listen to the show with Cora Opsahl (EP452) for more about how their health plan, as just one example, saved $30 million a year just pushing a huge expensive health system, consolidated one, out of their network and navigating patients to more affordable sites of care. This matters to pharma companies because hospital system prices are currently crushing in many areas of the country, really impacting patient affordability. But there are better or worse options from an affordability standpoint in some of these geographies. To state the obvious, if an infusion of the same drug costs 10 times more if a patient shows up in one care setting versus another, that latter place, not affordable for patients. And by the way, that is not hyperbole of any kind. There are plenty of examples where literally an infusion of the same drug, same dosage will cost 10 times more if a patient goes one place versus another. But, again, it's not affordable. The patient cost share might be 10 times higher if it's coinsurance, if the patient goes to that latter place. And that latter 10x more of the cost place also just added 10x the cost to the PAP program or the foundation debit column. All of this is really relevant to Pharma. And just to pile on here because now I'm on a roll, another reason why this matters, these striking price variations between care settings, if we're talking about product value, and if the price the patient or the plan sponsor is paying is 10x the cost of the ingredients, nobody's doing that math and separating out the cost of ingredients from the, you know, total cost of the infusion. It is one lump sum number. So, if we're defining value as outcomes divided by cost and now the cost to the plan sponsor is 10x, product value just got reduced by 10x. Just in case anyone is confused here, and you probably know this, but many forget that the whole ASP (average selling price) plus 6% provider reimbursement—so, if that's what you're thinking and you're wondering how the 10x transpires—that ASP plus 6% provider reimbursement is only for Medicare kinds of plans. Hospitals can and do negotiate much higher reimbursements for commercial plans, and those carriers that have commercial lines of business and also MA (Medicare Advantage) books of business even allegedly actually negotiate higher commercial reimbursements so that they can get lower Medicare Advantage rates. Right, and you can see why, because the MA dollars are coming out of their own capitated pockets, whereas the commercial rates are being paid for by the ultimate purchasers, the plan sponsors. Also mentioned in this episode are Reid Strategic; Mark Cuban; Cora Opsahl; Bruce Rector, MD; Shawn Gremminger; Nina Lathia, RPh, MSc, PhD; Autumn Yongchu; Erik Davis; and Marty Makary, MD, MPH. Additional related episodes: EP380 with Mark Miller, PhD, on pharma communications. EP371 with Erik Davis and Autumn Yongchu on buy and bill versus pharmacy bagging. EP426 with Nina Lathia, RPh, MSc, PhD, on cost containment versus value-based drug purchasing. EP435 with Dan Mendelson from Morgan Health on how employers should consider pharma purchasing. EP365 with Scott Haas on PBM contracts and drug rebates. EP293 with Dea Belazi, PharmD, MPH, from AscellaHealth on co-pay cards, co-pay accumulators, and co-pay maximizers.   You can learn more by subscribing to Brian's newsletter and by following him on LinkedIn.   Brian Reid has nearly three decades of experience in healthcare journalism, public affairs, and public relations with a specialty in explaining the economics of the healthcare system. He is the founder of Reid Strategic, a communications consultancy, and a senior fellow at the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center. At Reid Strategic, Brian counsels industry leaders on the best way to communicate on complex policy, access, pricing, and reimbursement issues in ways that critical audiences can understand. Brian's core belief is that we can't build a better healthcare system until everyone understands the system we have today. Reid Strategic offers communications strategy and execution around corporate, brand, and policy challenges, from prelaunch approaches to lifecycle management. Prior to founding Reid Strategic, Brian built and led Real Chemistry's Value+Access Communications practice, the largest such group dedicated to issues of value. Brian has written extensively for a range of audiences. At Reid Strategic, he publishes the daily Cost Curve newsletter; and his past experience includes coverage of the health science/policy beat for Bloomberg News, creation of patient education materials for the National Institutes of Health, and features in publications ranging from the Washington Post to Nature Biotechnology to Men's Health. He has a bachelor's degree in biology and political science from Emory University and a master's degree from the Columbia University School of Journalism.   08:29 Why is it important to understand the term “value” in respect to medicine? 10:07 Why is it important to consider all the players affected by the idea of this “value”? 11:06 Who are the ultimate purchasers in Pharma? 12:23 Findings of the Kaiser Employer Health Benefits Survey. 14:52 Why does it matter that we consider what value looks like to all players affected by Pharma? 16:46 EP300 with Bruce Rector, MD. 18:38 EP448 (Part 1) with Shawn Gremminger. 20:04 What does Pharma need to do to showcase their value when PBMs are often “locked in” at the moment? 23:11 Why Brian is celebrating companies that put their prices in their press releases. 32:31 Why does Pharma have an obligation to explain their value? 33:16 EP426 with Nina Lathia, RPh, MSc, PhD. 33:39 Why is it important for Pharma to keep an eye on hospital monopoly behavior? 35:55 EP370 with Erik Davis and Autumn Yongchu. 37:44 Why Pharma needs to capitalize on alignment.   You can learn more by subscribing to Brian's newsletter and by following him on LinkedIn.   Brian Reid, of Reid Strategic, discusses #pharma and #patientaffordability on our #healthcarepodcast. #healthcare #podcast #financialhealth #primarycare #patientoutcomes #healthcareinnovation   Recent past interviews: Click a guest's name for their latest RHV episode! Dr Beau Raymond, Brendan Keeler, Claire Brockbank, Cora Opsahl, Dan Nardi, Dr Spencer Dorn (EP451), Marilyn Bartlett, Dr Marty Makary, Shawn Gremminger (Part 2), Shawn Gremminger (Part 1), Elizabeth Mitchell (Summer Shorts 9)  

What can be scarier than Halloween ghouls? How about a trip through the LSD underground?Today, the Spotlight shines On Erik Davis, and this trip is no bummer. Erik is an author, award-winning journalist, and teacher in San Francisco. He is the author, most recently, of Blotter: The Untold Story of an Acid Medium_, a study of LSD blotter art. And that's what he's joined us to talk about.Erik also wrote one of my favorite books, High Weirdness: Drugs, Esoterica, and Visionary Experience in the Seventies. His scholarly and popular essays on music, technoculture, drugs, and spirituality have appeared in many books, magazines, and journals. He is also one of the founders of Alembic, a center in Berkeley, California, devoted to meditation, movement, and visionary arts and culture.Enjoy our talk about the hysteria surrounding LSD, the cultural significance and risks of the LSD blotter art trade, as well as the intersection between that art and the illicit drug market.–Dig DeeperVisit Erik Davis at techgnosis.comSubscribe to Erik Davis's newsletter Burning Shore at burningshore.comPurchase Blotter: The Untold Story of an Acid Medium and other books by Erik Davis from MIT Press, Bookshop, Amazon, Barnes & Noble, and Powell'sEight LSD Blotters That Defined Psychedelic CultureInside the LSD Museum That the DEA Somehow Hasn't Torn to the Ground‘I'm high as a Georgia pine': Dock Ellis's no-hitter on LSD, 50 years onDig into this episode's complete show notes at spotlightonpodcast.com–• Did you enjoy this episode? Please share it with a friend! You can also rate Spotlight On ⭐️⭐️⭐️⭐️⭐️ and leave a review on Apple Podcasts.• Subscribe! Be the first to check out each new episode of Spotlight On in your podcast app of choice.• Looking for more? Visit spotlightonpodcast.com for bonus content, web-only interviews + features, and the Spotlight On email newsletter. You can also follow us on Instagram, Facebook, and Mastodon. Hosted on Acast. See acast.com/privacy for more information.

What can be scarier than Halloween ghouls? How about a trip through the LSD underground?Today, the Spotlight shines On Erik Davis, and this trip is no bummer. Erik is an author, award-winning journalist, and teacher in San Francisco. He is the author, most recently, of Blotter: The Untold Story of an Acid Medium_, a study of LSD blotter art. And that's what he's joined us to talk about.Erik also wrote one of my favorite books, High Weirdness: Drugs, Esoterica, and Visionary Experience in the Seventies. His scholarly and popular essays on music, technoculture, drugs, and spirituality have appeared in many books, magazines, and journals. He is also one of the founders of Alembic, a center in Berkeley, California, devoted to meditation, movement, and visionary arts and culture.Enjoy our talk about the hysteria surrounding LSD, the cultural significance and risks of the LSD blotter art trade, as well as the intersection between that art and the illicit drug market.–Dig DeeperVisit Erik Davis at techgnosis.comSubscribe to Erik Davis's newsletter Burning Shore at burningshore.comPurchase Blotter: The Untold Story of an Acid Medium and other books by Erik Davis from MIT Press, Bookshop, Amazon, Barnes & Noble, and Powell'sEight LSD Blotters That Defined Psychedelic CultureInside the LSD Museum That the DEA Somehow Hasn't Torn to the Ground‘I'm high as a Georgia pine': Dock Ellis's no-hitter on LSD, 50 years onDig into this episode's complete show notes at spotlightonpodcast.com–• Did you enjoy this episode? Please share it with a friend! You can also rate Spotlight On ⭐️⭐️⭐️⭐️⭐️ and leave a review on Apple Podcasts.• Subscribe! Be the first to check out each new episode of Spotlight On in your podcast app of choice.• Looking for more? Visit spotlightonpodcast.com for bonus content, web-only interviews + features, and the Spotlight On email newsletter. You can also follow us on Instagram, Facebook, and Mastodon. Hosted on Acast. See acast.com/privacy for more information.

The Deadcast crosses the Blue Ridge Mountains for the Dead's only show in Huntington, West Virginia, including close looks at the innovative fashion and LSD scenes then emerging in Dead parking lots, and the conclusion of a rare 1978 interview with Jerry Garcia.Guests: Kathy Sublette, Rob Bleetstein, Bob Wagner, Bob Minkin, Jay Blakesberg, David Lemieux, Steve Silberman, Erik Davis, Annabelle WalshSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

October 18th - Stewart Dobson, Erik Davis, Juju Chang, Mark Farner

October 11th - Stewart Dobson, Erik Davis, TJ Newman, Matt Fraser and Katie Santry

October 3rd - Yoram Kenig, Erik Davis, Nicola Marsh, Rian Kanouff

September 27th - Stewart Dobson, Erik Davis, Howard Blum

This week on Future Fossils, I meet with the wonderful Tim Adalin of Voicecraft. Watch us get to know each other a little bit better on a swapcast (his edit here) that throws a long loop around the world. Tim is precisely the kind of thoughtful investigator I love to encounter in conversation. Enjoy!✨ Support This Work• Buy my brain for hourly consulting or advisory work on retainer• Become a patron on Substack or Patreon• Help me find backing for my next big project Humans On The Loop• Buy the books we discuss from my Bookshop.org reading list• Buy original paintings and prints or commission new work• Join the conversation on Discord in the Holistic Technology & Wise Innovation and Future Fossils servers• Make one-off donations at @futurefossils on Venmo, $manfredmacx on CashApp, or @michaelgarfield on PayPal• Buy the show's music on Bandcamp — intro “Olympus Mons” from the Martian Arts EP & outro “Sonnet A” from the Double-Edged Sword EP✨ Chapters00:00 Introduction to Lifelong Collaboration and Innovation 01:18 The Role of Art and Holistic Processes in Innovation 01:37 Challenges in Fostering Collective Intelligence 03:37 The Intersection of Science and Art 03:49 Introduction to the Special Episode with Tim Adelin06:36 Exploring Technology and Human Civilization 07:27 The Importance of Trust and Dialogue in Organizations 42:41 The Rise of Wise Innovation 43:34 The Information Scaling Problem 44:49 The Epidemic of Loneliness 46:58 The Obsession with Novelty 50:21 The Role of Cultural Intelligence 53:25 The Finite Time Singularity 01:01:15 The Future of Human Collaboration✨ Takeaways* Wise innovation requires reconnecting with the purpose and mission of organizations and cultivating a field that allows for the ripening of ideas and contributions.* The tension between exploration and exploitation is a key consideration in navigating large networks and organizations.* Play, creativity, and the integration of holistic, playful, and noisy approaches are essential for innovation and problem-solving.* Deep and authentic relationships are crucial for effective communication and understanding in a world of information overload.* The need for wisdom to keep pace with technology is a pressing challenge in the modern world. Innovation is a crossroads between the need for integration and the obsession with novelty and productivity.* Different types of innovation are needed, and movement in one dimension is not equivalent to movement in another.* The erosion of values and the loss of context can occur when organizations prioritize innovation and novelty.* A tripartite regulatory structure, consisting of industry, art/culture/academia, and government, is necessary to prevent the exploitation of power asymmetries.* Small-scale governance processes and the importance of care and balance in innovation are key to a more sustainable and wise approach.✨ MentionsAlison Gopnik, Iain McGilchrist, Brian Arthur, Bruce Alderman, Andrew Dunn, Turquoise Sound, John Vervaeke, Naomi Klein, Erik Davis, Kevin Kelly, Mitch Mignano, Rimma Boshernitsan, Geoffrey West, Brian Enquist, Jim Brown, Elisa Mora, Chris Kempes, Manfred Laubichler, Annalee Newitz, Venkatesh Rao, Daniel Schmachtenberger, Nate Hagens, Yanis Varoufakis, Ferananda Ibarra, Josh Field, Michel Bauwens, John Pepper, Kevin Kelly, Gregory Landua, Sam Bowles, Wendy Carlin, Kevin Clark, Stuart Kauffman, Jordan Hall, William Irwin Thompson, Henry Andrews This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit michaelgarfield.substack.com/subscribe

September 20th - Stewart Dobson, Erik Davis

September 13th - Stewart Dobson, Erik Davis, Ana Garcia

Erik Davis stands tall at the intersection between mysticism, technology, and counterculture. He's one of my favorite writers, the author of many stupendous books, among them "TechGnosis: Myth, Magic, and Mysticism in the Age of Information," "Nomad Codes," as well as "High Weirdness" a highly entertaining book that explores 1970s counterculture and its relationship with altered states of consciousness. Erik is also an Esalen faculty member, having recently taught a course on Embodied Writing and Spiritual Practice. In this conversation, we went into his new book, "Blotter," an extended meditation on LSD blotter art and the culture that surrounds it. We also found time to veer off into a host of topics, including Terence McKenna, John C. Lilly, Dick Price, madness, Stan Grof, the spiritual emergency network, prep-school deadheads, the Village Voice, the Internet and Erik's theory that it kills subcultures, the phenomenon of what Erik calls "cannabis thinking," how he was never much of a "cannabis writer," tape machines and their place in the counterculture, the Merry Pranksters, Phillip K. Dick, Bay Area Poster art, the DEA and its own little zine - and much more. Erik is one of the cofounders of the Berkeley Alembic - a nonprofit bodymind center committed to experiments in transformation. https://berkeleyalembic.org/ You can also find his collected works at Techgnosis: https://techgnosis.com/

Outrage is boiling over in Israel against the Netanyahu government after six hostages were killed in Gaza. The country now faces a nationwide strike following mass demonstrations over the weekend, demanding the prime minister step down. CBS News foreign correspondent Imtiaz Tyab has the latest.Protesters in Israel say Prime Minister Benjamin Netanyahu has stalled a Gaza cease-fire and hostage deal while more than 100 people are still believed to be held by Hamas. The hostages include 20-year-old Edan Alexander, a New Jersey native who volunteered to serve in the IDF after high school. His parents, Adi and Yael Alexander, join “CBS Mornings.”There are several anticipated films coming out this fall, including "Beetlejuice Beetlejuice,​" "Joker: Folie à Deux," "Transformers One" and "Wicked." Fandango's managing editor, Erik Davis, joins "CBS Mornings" with his must-see movie picks.Meghan Joyce is the founder and CEO of Duckbill, a virtual assistant service for busy adults. The company says it uses artificial intelligence along with human "co-pilots" to "check off your to-dos until they're done, exactly the way you would." Joyce joins "CBS Mornings" as part of the series, "Changing the Game."See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

August 30th - Stewart Dobson, Erik Davis, Clair Titley

August 23rd - Erik Davis, Brian Bishop, Phil Calla, Hari Cameron

August 16th - Erik Davis, Lauren Buglioli

Erik Davis' “Blotter” is really three books in one: It's about the way LSD tabs were embedded in blotter paper so they wouldn't be detected by the authorities; it's also a deep dive into the psychedelic underground; and finally, it's an art book — gorgeously illustrated, with lots of very trippy blotter art. Steve talks with Erik about the wildness of psychedelic experiences and whether they reveal a deeper dimension of consciousness.Original Air Date: July 20, 2024Guests: Erik DavisFor more from Luminous: ttbook.org/luminous

Erik Davis, an American writer, scholar, journalist and public speaker whose writings have ranged from rock criticism to cultural analysis to creative explorations of esoteric mysticism, takes us on an unforgettable exploration into the world of LSD blotter art with his latest book, "Blotter: The Untold Story of an Acid Medium". We discuss the fascinating history of this unique street medium and discover the art's profound cultural significance, spurred by Davis's personal connection with Mark McLeod, the largest collector of blotter art. Erik's multidisciplinary approach shines through as he navigates the labyrinthine process of documenting countercultural history, blending personal accounts and obscure artifacts to craft a compelling narrative. He shares with us the fascinating process of documenting countercultural history through the kaleidoscopic lens of LSD distribution and blotter art. Erik explains the challenge of piecing together stories from a variety of sources, blending personal anecdotes with historical records to create a rich tapestry that blurs myth and fact. We delve into the evolution of LSD formats, the complex influence of the Grateful Dead on the acid scene, and the potential involvement of intelligence agencies like the CIA. Erik reflects on his personal experiences with psychedelics and how they shaped his career, offering a unique perspective on the modern, lab-created drug compared to organic psychedelics. Tune in for a rich and insightful conversation that navigates the multifaceted landscape of psychedelic culture. Check out Erik's website https://techgnosis.com/ and check out his Substack at www.burningshore.com -For THE BEST MUSHROOM CHOCOLATES EVER go over to @MELTMUSHROOMS ON INSTAGRAM and shoot them a DM for a menu of all the amazing flavors of MUSHROOM CHOCOLATE BARS and MAKE SURE TO TELL THEM NSR SENT YOU FOR $20 OFF YOUR FIRST ORDER! -FREE SHIPPING from Shop Tour Bus Use The PROMO CODE: nosimpleroad -venuellama.com is back! Head over and sign up for your free Llama Account now and start rating venues! INTRO MUSIC PROVIDED BY - Young & Sick MUSIC IN THE COMMERCIALS BY AND USED WITH PERMISSION OF: CIRCLES AROUND THE SUN OUTRO MUSIC BY AND USED WITH PERMISSION OF: CHILLDREN OF INDIGO No Simple Road is part of OSIRIS MEDIA. Osiris Media is the leading storyteller in music, combining the intimacy of podcasts with the power of music.

Erik Davis, PhD, is an author, award-winning journalist, sometimes podcaster, and popular speaker based in San Francisco. He is the author of 6 books which include: Blotter: The Untold Story of an Acid Medium (MIT Press) High Weirdness: Drugs, Esoterica, and Visionary Experience in the 70s (MIT Press/Strange Attractor Press). Nomad Codes: Adventures in Modern Esoterica (Yeti, 2010). The Visionary State: A Journey through California's Spiritual Landscape (Chronicle, 2006), with photographs by Michael Rauner. Led Zeppelin IV (Continuum, 2005) - 33 1/3 volume. TechGnosis: Myth, Magic, and Mysticism in the Age of Information (Crown, 1998; republished by North Atlantic Press). Topics Discussed In This Episode:  Erik's work and his areas of interest (00:04:37) Deciding what projects to dedicate his time to (00:06:36) Finding his authentic voice (00:13:27) The transformation of subcultural movements into mainstream cultural (00:13:18) Trying to make sense out of confusing times (00:24:22) Learning to appreciate banality, and simplicity in an increasingly more technologically focused world (00:36:33) Separating yourself from devices and giving yourself the space to allow the muse to enter (00:46:15) The consensus trance and becoming more conscious (00:49:38) Having good “epistemological hygene” (00:57:04) Getting back to basic joys (01:05:09) Erik's new book “Blotter: The Untold Story of an Acid Medium” (01:07:09) artistdecoded.com techgnosis.com x.com/erik_davis burningshore.com

In Episode 442 of 'Relentless Health Value,' host Stacey Richter shares an intriguing outtake from a previous episode featuring Andreas Mang, senior managing director at Blackstone, discussing the critical issue of cost management in oncology side effect treatment. The conversation delves into the inefficiencies and patient harms caused by inadequate side effect management, particularly dehydration due to chemotherapy, and the resulting financial burdens on employers, taxpayers, and patients.  Stacey explores the importance of a value-based mindset in drug purchasing, integrating oncology care, and the potential financial and health benefits of better side effect management. She highlights various expert opinions and studies supporting these points, encouraging listeners to reconsider their approach to healthcare cost structures and patient care protocols. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe.  01:12 Andreas Mang on oncology medication side effect management. 03:12 Mark Lewis, MD's Tweet. 03:39 Celena Latham's response. 04:22 How integrative oncology can save money and what it looks like. 04:47 EP157 with Ethan Basch, MD. 06:20 Why PBMs saving money doesn't necessarily mean savings for employers and payers. 07:36 EP435 with Dan Mendelson. 08:20 EP372 with Cora Opsahl. 08:40 EP331 with Al Lewis. 09:50 Stacey's second rumination. 10:19 Why having a value mindset when purchasing is a thing. 10:42 Stacey's third rumination. 12:03 EP370 with Erik Davis and Autumn Yongchu. 13:07 Why FFS does not pay or pay adequately for side effect management. 14:31 Stacey's final rumination. 17:08 Summarizing Stacey's four ruminations on this topic.

Rachel Khong joins Eric Newman to discuss her latest novel, Real Americans. Divided into three parts that each trace the experiences of different generations of a Chinese American family, the book delves into the thickets of identity, exploring how cultural strictures and the chaos of love shape our reality. The first section, set in 1999, recounts the romance between Lily, a second generation Chinese American media intern in New York, and Matthew, the WASPy private equity investor of the company where she struggles to eke out a living. The second section transports us to Seattle in 2021, where Lily's son, Nick, is navigating the end of high school and early college years with his father, Matthew, conspicuously absent. When Nick reconnects with Matthew through a DNA ancestry test, old wounds heal even as new ones are opened up in the wake of long-buried family secrets. In the final section, Nick's grandmother reflects on her experience fleeing Mao Zedong's China to make a new life in the United States, while trying to reconcile with a tattered and scattered family in present-day San Francisco. As these three lives are woven together and torn apart, Real Americans moves propulsively through questions of race, class, and gender as its characters work to understand their relationship to inheritance, variously conceived, around the tripwires of silence, desire, and pain. Also, Erik Davis, author of Blotter: The Untold Story of an Acid Medium, returns to recommend Dale Pendell's Pharmako Trilogy.

Get the full 2 hour interviews with THC+ Sign-Up Options: Subscribe via our website and get the Plus show on your usual podcast apps. Subscribe via Patreon, including the full Plus archive, a dedicated RSS feed, Spotify, & payment through Paypal. Subscribe via check, cash, money order, or crypto with the information at the bottom of […] The post Erik Davis | LSD, Drug Portals, Psychedelic Animism, & The Alien Interface appeared first on The Higherside Chats.

To hear the full episode, subscribe at patreon.com/TrueAnonPod -------- Erik Davis, scholar of the weird and esoteric, joins us for part two of a long conversation about the legacy of Philip K. Dick, Silicon Valley technopolypse, the future of California, and more from his forthcoming book Blotter: The Untold Story of an Acid medium. Erik Davis's substack: www.burningshore.com/

We join Erik Davis, scholar of the weird and esoteric, in his home for a long conversation about California ideological supremacy, crazy trips, the history of LSD, and his forthcoming book Blotter: The Untold Story of an Acid medium. Erik Davis's substack: www.burningshore.com/